Can l-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?-Reference-Cited by-同舟云学术

Can l-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Published:2019-07 Issue:7 Volume:31 Page:878-884
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Hiraoka Atsushi,Kiguchi Daisuke,Ninomiya Tomoyuki,Hirooka Masashi,Abe Masanori,Matsuura Bunzo,Hiasa Yoichi,Michitaka Kojiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation;Hiraoka;J Gastroenterol,2015

2. Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease;Hiraoka;Eur J Gastroenterol Hepatol,2016

3. Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease;Koya;Hepatol Res,2017

4. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis;Hiraoka;Eur J Gastroenterol Hepatol,2017

5. L-carnitine suppresses loss of skeletal muscle mass in patients with liver cirrhosis;Ohara;Hepatol Commun,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of branched-chain amino acid supplementation and exercise on quadriceps muscle quantity and quality in patients with cirrhosis as assessed by ultrasonography: A randomized controlled trial;Clinical Nutrition ESPEN;2024-06

2. Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement);Russian Journal of Gastroenterology, Hepatology, Coloproctology;2024-03-19

3. Child–Pugh grade deterioration stratified by the etiology after transcatheter arterial chemoembolization as initial treatment for hepatocellular carcinoma;Scientific Reports;2024-02-14

4. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management;World Journal of Gastroenterology;2023-12-14

5. Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan;Medicina;2023-08-22